skip to main content
Idioma:
Refinado por: assunto: Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use remover assunto: Remission Induction remover Female remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Cavo, Michele, Prof ; Tacchetti, Paola, MD ; Patriarca, Francesca, MD ; Petrucci, Maria Teresa, MD ; Pantani, Lucia, MD ; Galli, Monica, MD ; Di Raimondo, Francesco, Prof ; Crippa, Claudia, MD ; Zamagni, Elena, MD ; Palumbo, Antonio, MD ; Offidani, Massimo, MD ; Corradini, Paolo, Prof ; Narni, Franco, MD ; Spadano, Antonio, MD ; Pescosta, Norbert, MD ; Deliliers, Giorgio Lambertenghi, Prof ; Ledda, Antonio, MD ; Cellini, Claudia, MD ; Caravita, Tommaso, MD ; Tosi, Patrizia, MD ; Baccarani, Michele, Prof

The Lancet (British edition), 2010-12, Vol.376 (9758), p.2075-2085 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure

TOSI, P ; ZAMAGNI, E ; RONCONI, S ; BENNI, M ; MOTTA, M. R ; RIZZI, S ; TURA, S ; CAVO, M

Leukemia, 2000-07, Vol.14 (7), p.1310-1313 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
3
Anaplastic large cell lymphoma Hodgkin's-like : A randomized trial of ABVD versus MACOP-B with and without radiation therapy
Anaplastic large cell lymphoma Hodgkin's-like : A randomized trial of ABVD versus MACOP-B with and without radiation therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anaplastic large cell lymphoma Hodgkin's-like : A randomized trial of ABVD versus MACOP-B with and without radiation therapy

ZINZANI, P. L ; MARTELLI, M ; GHERLINZONI, F ; MORETTI, L ; DE RENZO, A ; MAZZA, P ; PAVONE, E ; SABATTINI, E ; AMENDOLA, A ; BENDANDI, M ; PILERI, S. A ; MANDELLI, F ; MAGAGNOLI, M ; TURA, S ; ZACCARIA, A ; RONCONI, F ; CANTONETTI, M ; BOCCHIA, M ; MARRA, R ; GOBBI, M ; FALINI, B

Blood, 1998-08, Vol.92 (3), p.790-794 [Periódico revisado por pares]

Washington, DC: The Americain Society of Hematology

Texto completo disponível

Citações Citado por
4
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy

Lemoli, Roberto M. ; Martinelli, Giovanni ; Zamagni, Elena ; Motta, Maria Rosa ; Rizzi, Simonetta ; Terragna, Carolina ; Rondelli, Roberto ; Ronconi, Sonia ; Curti, Antonio ; Bonifazi, Francesca ; Tura, Sante ; Cavo, Michele

Blood, 2000-04, Vol.95 (7), p.2234-2239 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
5
A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol)
A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol)

Ferrara, Felicetto ; Vecchio, Luigi Del ; Mele, Giuseppina ; Rametta, Vincenzo ; Ronconi, Fioravante ; Montuori, Renato

Cancer, 1989-08, Vol.64 (4), p.789-792 [Periódico revisado por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.